Replies to post #24 on Cyberonics Inc. (CYBX)

[Tuff-Stuff]

CYBX Cyberonics Announces FDA Approval of Aspire High Capacity Generator for VNS Therapy

Press Release Source: Cyberonics, Inc. On Tuesday February 1, 2011, 4:46 pm

HOUSTON, Feb. 1, 2011 /PRNewswire/ -- Cyberonics, Inc. (Nasdaq:CYBX - News) today announced that the AspireHC™ (High Capacity) generator for use in vagus nerve stimulation (VNS) therapy was approved by the United States Food and Drug Administration (FDA) for commercial release.



The AspireHC generator (development name NXT HC) represents the fifth generation of VNS Therapy® technology. This product incorporates greater functionality for the benefit of patients and their physicians, including longer battery life, improved electronics and simplified features for programming.

The AspireHC generator is expected to be in limited commercial release in the United States in the Company's current quarter ending April 29, 2011. The company has applied for the CE Mark.

"The AspireHC generator will enhance the quality of life for VNS patients, and we are gratified that the FDA completed their review in an expeditious manner," said Dan Moore, Cyberonics' President and Chief Executive Officer. "In addition, this generator provides an important platform for future new product introductions, including the AspireSR seizure response system for which a European clinical trial is planned to start in the first half of calendar 2011."

To date, more than 60,000 patients worldwide have been implanted with the VNS Therapy System for epilepsy.

About Cyberonics, Inc. and the VNS Therapy® System

Cyberonics, Inc. is a medical technology company with core expertise in neuromodulation. The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics and the VNS Therapy System is available at www.cyberonics.com.

Safe harbor statement

[Murrieta]

Not just the device makers but the companies delivering the technology to the devices in the blue tooth app world.